Saturday 17 October 2026
Export AMIX’s income statement to Excel — free account
Autonomix Medical, Inc.
AMIX Healthcare Medical Devices
In the quarter to June 2026, EPS grew 77.7% and free cash flow fell 36.1%, each against the same quarter a year earlier.
2.85
0.08
−2.73%
Follow AMIX
| Mar '26 | Mar '25 | Mar '24 | Dec '23 | Mar '23 | Dec '22 | |
|---|---|---|---|---|---|---|
Current Ratio |
4.45 | 5.63 | 12.09 | 1.73 | 3.91 | — |
Net Debt/EBITDA |
0.41 | 0.80 | 0.64 | (0.08) | 0.43 | 0.00 |
Debt/Assets |
0.00% | 0.00% | 10.65% | 80.54% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.13 | (0.26) | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.73 | 0.72 | 0.43 | 1.40 | 0.93 | 2.27 |
Capex/Depreciation |
(0.83) | (0.08) | (0.23) | (0.46) | 0.00 | 0.00 |
Interest Coverage |
— | (65.84) | (152.28) | (88.61) | — | — |
| (238.89%) | (145.10%) | (1,517.56%) | 125.75% | 0.00% | 0.00% | |
| (192.06%) | (118.77%) | (275.07%) | (232.83%) | (460.12%) | 0.00% | |
ROIC |
0.00% | 0.00% | (34,176.14%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(283.55%) | (144.01%) | (178.75%) | (428.79%) | (309.01%) | 0.00% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | — | — |
Free Cash Flow per Share |
(35.78) | (98.36) | (134.69) | (0.23) | (64.83) | 0.00 |
Cash per Share |
20.39 | 108.63 | 173.90 | 0.06 | 30.24 | — |
Shareholders Equity per Share |
17.16 | 96.30 | 154.10 | (0.29) | 22.52 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
17.16 | 96.30 | 154.10 | (0.29) | 22.52 | 0.00 |
Free Cash Flow |
(12.29) | (8.27) | (6.67) | (4.38) | (1.85) | (1.23) |
Working Capital |
5.88 | 7.90 | 8.61 | 0.71 | 0.64 | — |
Capital Expenditures |
(0.01) | (0.01) | (0.02) | (0.02) | 0.00 | 0.00 |
Net Current Asset Value |
5.88 | 7.90 | 7.61 | (5.72) | 0.64 | 0.00 |
| Other line items | ||||||
Quick Ratio |
4.11 | 5.35 | 11.08 | 1.25 | 3.91 | — |
Depreciation/Fixed assets |
0.63 | 8.71 | 5.06 | 2.50 | 0.00 | 0.00 |
Cash ROIC |
(95.29%) | (48.00%) | (38.68%) | 149.90% | (122.86%) | 0.00% |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(35.76) | (98.19) | (134.30) | (0.23) | (64.83) | 0.00 |
Capex per Share |
(0.03) | (0.17) | (0.38) | 0.00 | 0.00 | 0.00 |
Average Payables |
0.69 | 0.58 | 0.58 | 0.42 | — | — |
Average Assets |
8.70 | 9.61 | 5.61 | 1.34 | 0.43 | — |
Average Common Equity |
7.00 | 7.86 | 1.02 | (2.48) | — | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates